Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Capital Expenditures (2018 - 2026)

TransMedics has reported Capital Expenditures over the past 8 years, most recently at -$42.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 63.2% year-over-year to -$42.0 million; the TTM value through Dec 2025 reached $1.8 million, down 14.99%, while the annual FY2025 figure was $1.8 million, 14.99% down from the prior year.
  • Capital Expenditures for Q4 2025 was -$42.0 million at TransMedics, down from $7.6 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $66.8 million in Q2 2024 and troughed at -$114.1 million in Q4 2024.
  • A 5-year average of $968800.0 and a median of $899000.0 in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: soared 42850.0% in 2021 and later crashed 15726.85% in 2024.
  • Year by year, Capital Expenditures stood at $859000.0 in 2021, then surged by 1178.35% to $11.0 million in 2022, then crashed by 93.35% to $730000.0 in 2023, then crashed by 15726.85% to -$114.1 million in 2024, then surged by 63.2% to -$42.0 million in 2025.
  • Business Quant data shows Capital Expenditures for TMDX at -$42.0 million in Q4 2025, $7.6 million in Q3 2025, and $9.1 million in Q2 2025.